...
首页> 外文期刊>Regulatory peptides. >Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.
【24h】

Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.

机译:雌激素的静脉内或脑室内给药均不影响大鼠GH,PRL,TSH和ACTH的分泌。

获取原文
获取原文并翻译 | 示例

摘要

To examine the effect of obestatin, a recently identified peptide derived from preproghrelin, on pituitary hormone secretion, obestatin was administered in anesthetized male rats. Intravenous administration of obestatin did not show any effect on plasma GH, PRL, ACTH and TSH levels. Since obestatin has been reported to have opposite effects of ghrelin in regulating food intake, gastric emptying and intestinal contractility, GH suppressive effect, which is opposite effect of ghrelin, was tested. Intravenous administration of GHRH or GHRP-2, a ghrelin receptor ligand, resulted in a marked plasma GH elevation. However obestatin did not show any effect on GHRH- or GHRP-2-induced GH rise. Furthermore intracerebroventricular administration of obestatin also did not influence plasma GH, PRL, ACTH and TSH levels. These findings suggest that obestatin has no effect on pituitary hormone secretions despite the presence of GPR39, a receptor for obestatin, in the pituitary.
机译:为了检查肥胖抑制素(一种最近发现的前促胰泌素释放肽)对垂体激素分泌的作用,在麻醉的雄性大鼠中施用了肥胖抑制素。静脉注射抑抑素对血浆GH,PRL,ACTH和TSH水平无影响。由于据报道肥胖抑制素在生长素释放肽调节食物摄取,胃排空和肠收缩性方面具有相反的作用,因此测试了与生长素释放肽相反的生长激素抑制作用。 GHRH或GHRP-2(一种生长素释放肽受体配体)的静脉内给药导致血浆GH明显升高。然而,肥胖抑制素对GHRH或GHRP-2诱导的GH升高没有显示任何作用。此外,脑室内服用抑素肽也不会影响血浆GH,PRL,ACTH和TSH水平。这些发现表明,尽管在垂体中存在Gost39,Obestatin的受体,Obestatin对垂体激素的分泌没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号